CELLIVERY THERAPEUTICS
Cellivery’s therapeutic drug candidates are being developed for the prevention of life-threatening lethal diseases, including various cancer. The company’s subsequent drug discovery programs will focus on other diseases, in which the transient suppression of either symptoms or etiology would produce long-term benefits, that are both cost-effective and associated with a high quality of life. Cellivery Therapeutics Inc. was founded by Dr. Daewoong Jo, President and CEO in March of 2014. Its earliest notions have been prepared, however, when Dr. Jo began to study for his doctoral thesis at Vanderbilt University, Nashville, TN, USA in 1997.
CELLIVERY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-03-06
Address:
Mapo, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.cellivery.com
Total Employee:
101+
Status:
Active
Contact:
+82-2-6495-7866~7
Technology used in webpage:
SPF Nginx Korea Telecom Cafe24 DNS
Similar Organizations
Avammune Therapeutics
Avammune Therapeutics is a drug discovery company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Onspira Therapeutics
Onspira Therapeutics operates as a clinical-stage biopharmaceutical company.
SIRS Therapeutics
SIRS Therapeutics operates as a therapeutics company.
Founder
Stock Details
Official Site Inspections
http://www.cellivery.com Semrush global rank: 3 M Semrush visits lastest month: 5.41 K
- Host name: 203.245.24.33
- IP address: 203.245.24.33
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Cellivery Therapeutics"
Cellivery Therapeutics - Crunchbase Company Profile
Cellivery’s therapeutic drug candidates are being developed for the prevention of life-threatening lethal diseases, including various cancer. The company’s …See details»
cellivery
Cellivery’s therapeutic drug candidates are being developed for the prevention of life-threatening lethal diseases, including various cancer. The company’s subsequent drug discovery programs will focus on other diseases, in which …See details»
Cellivery Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cellivery Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 15 literature, Disease Domain:Nervous System Diseases, …See details»
Cellivery Therapeutics Inc - Company Profile and News
Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities.See details»
Cellivery Company Profile - Office Locations, Competitors, …
Cellivery has 2 employees at their 1 location and ₩18.86 b in annual revenue in FY 2023. See insights on Cellivery including office locations, competitors, revenue, financials, executives, …See details»
Cellivery - Company Profile - Tracxn
Aug 17, 2021 Cellivery is a protein-based drug discovery/development company commercializing its platform technology for effective delivery of therapeutic macromolecules to …See details»
Cellivery - Overview, News & Similar companies | ZoomInfo.com
Cellivery Therapeutics Inc, was founded by Dr. Daewoong Jo, President and CEO in March of 2014. Its earliest notions have been prepared, however, when Dr. Jo began to study for his …See details»
cellivery
President, Korea Human Proteome Organization (KHUPO) President, Asiaoceania Protein Organization (AOHUPO) President, World Human Proteome Organization (HUPO) President, Korean Society for Biochemistry and …See details»
Cellivery Therapeutics Company Profile 2024: Stock …
Cellivery Therapeutics’s EPS for 12 months was -$2.31. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial data in the industry.See details»
Cellivery Therapeutics - VentureRadar
Cellivery is a biotech company developing innovative drug candidates with cell-/tissue-permeability based on Cellivery’s proprietary Therapeuticmolecule Systemic Delivery …See details»
Organization: Cellivery Therapeutics - Cbonds.com
Organization: Cellivery Therapeutics Organization name. Cellivery Therapeutics, Inc. Country name. Republic of Korea Country of registration-Industry. Miscellaneous Healthcare: Products …See details»
Cellivery extends global clinical trials of Covid-19 immunotherapy …
May 31, 2021 Recently, Cellivery Therapeutics Inc announced that it will expand the clinical development of Covid-19 immunotherapy drug iCP-NI to include India and Europe. ... OPIS is …See details»
Cellivery sure to win licensing deal with top pharma company
May 7, 2020 “A global pharmaceutical company is conducting a verification test on therapeutic delivery technologies (of four biotech firms). I’m sure we will beat the three other biotech firms …See details»
cellivery
BUSINESS MODEL. TSDT provides a powerful method to identify and validate potential therapeutic targets. Thus, Cellivery is developing TSDT applied cargos such as small …See details»
cellivery
Cellivery Therapeutics Inc. was founded by Dr. Daewoong Jo, President and CEO in March of 2014. Its earliest notions have been prepared, however, when Dr. Jo began to study for his …See details»
Cellivery faces delisting as it receives auditor’s ‘disclaimer of ...
Aug 16, 2023 Cellivery has received a “disclaimer” of opinion on the first half-year report from its auditor. The company's shares are suspended from trading, drawing the industry's attention to …See details»
Cellivery Reviews: What Is It Like to Work At Cellivery?
3 Cellivery reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
cellivery
To develop improved hydrophobic CPPs, Cellivery analyzed sequences from all 1st and 2nd generation hydrophobic CPP sequences and identified 6 ‘critical factors’ associated with …See details»
cellivery
However, Cellivery’s proprietary Therapeuticmolecule Systemic Delivery Technology (TSDT) allows functionally active macromolecules to rapidly transverse cellular membranes. The …See details»